Cancer Gene Therapy Market Analysis: Opportunities, Innovations, and Growth Potential Through 2030

BySheetal Gajbhiye

The global Cancer Gene Therapy Market was valued at USD 1.76 billion in 2021, and it is projected to grow to USD $3.99 Billion By 2030. During the forecast period from 2030, the market is estimated to rise at a compound annual growth rate (CAGR) of 9.6% This upward trajectory is largely fueled by The industry is projected to witness significant growth during the forecast period, primarily driven by the rising prevalence of cancer. According to the World Health Organization (WHO), cancer remains the second leading cause of death globally, highlighting the growing need for effective diagnostic and treatment solutions.

Market Definition

Cancer Gene Therapy Market Encompasses therapies that modify or replace genes to treat or prevent cancer, offering personalized and targeted treatment approaches.

Key Report Highlights  

  • The report highlights the key region that accounts for the highest revenue share in the global Cancer Gene Therapy market.
  • It identifies the leading country within this region that makes a significant contribution to the market’s overall performance.
  • The report outlines the dominant segment that holds a major share of the market.
  • It also emphasizes the fastest-growing segment projected to gain strong traction during the forecast period.
  • Qualitative and quantitative market analysis have been used to provide an in-depth understanding of the market.

Market Overview: Key Figures at a Glance

  • Market Value in 2021: USD 1.76 billion
  • Projected Market Size in 2030: USD $3.99 Billion
  • Anticipated CAGR 2030: 9.6%

Get access to the full report or request a complimentary sample for in-depth analysis: https://www.polarismarketresearch.com/industry-analysis/cancer-gene-therapy-market 

Market Growth Drivers

The growing prevalence of cancer is a major driver of the cancer gene therapy market, as the disease remains the second leading cause of death worldwide. Key contributing factors include tobacco use, alcohol consumption, physical inactivity, high body mass index (BMI), and poor dietary habits, such as low intake of fruits and vegetables.

In addition, the regulatory landscape is becoming more supportive, further fueling market growth. Since cancer gene therapy directly impacts patient health, stringent regulations ensure the production and post-marketing safety of vectors, with no tolerance for defects. This strict quality control, combined with the availability of high-quality therapeutic vectors, strengthens market expansion.

Market Key Players

The competitive landscape features a mix of long-standing companies and emerging contenders. Leading players are actively pursuing R&D initiatives and strategic moves to strengthen their market position. Notable participants include

Add key players by referring to the RD for the Cancer Gene Therapy market available on our website.

  • Altor Bioscience Corporation
  • SiBiono
  • Shanghai Sunway
  • Biotech Company Limited
  • BioCancell
  • GlobeImmune, Inc.
  • Aduro Biotech
  • OncoGeneX
  • New Link Genetics
  • ZioPharm Oncology
  • Genelux Corporation
  • Novartis AG

Similar Posts